PDT Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-31,326
| Closed | -$923K | – | 564 |
|
|
2023
Q3 | $923K | Sell |
31,326
-56,403
| -64% | -$1.66M | 0.12% | 302 |
|
|
2023
Q2 | $2.86M | Sell |
87,729
-112
| -0.1% | -$3.65K | 0.39% | 62 |
|
|
2023
Q1 | $3.09M | Buy |
87,841
+44,294
| +102% | +$1.56M | 0.42% | 71 |
|
|
2022
Q4 | $2M | Buy |
+43,547
| New | +$2M | 0.32% | 78 |
|
|
2020
Q2 | – | Sell |
-102,200
| Closed | -$1.21M | – | 697 |
|
|
2020
Q1 | $1.21M | Buy |
102,200
+22,800
| +29% | +$269K | 0.1% | 210 |
|
|
2019
Q4 | $842K | Buy |
79,400
+30,400
| +62% | +$322K | 0.05% | 314 |
|
|
2019
Q3 | $558K | Sell |
49,000
-7,122
| -13% | -$81.1K | 0.03% | 332 |
|
|
2019
Q2 | $631K | Sell |
56,122
-7,309
| -12% | -$82.2K | 0.04% | 286 |
|
|
2019
Q1 | $513K | Buy |
63,431
+27,978
| +79% | +$226K | 0.03% | 315 |
|
|
2018
Q4 | $224K | Buy |
35,453
+48
| +0.1% | +$303 | 0.01% | 390 |
|
|
2018
Q3 | $349K | Sell |
35,405
-9,595
| -21% | -$94.6K | 0.01% | 395 |
|
|
2018
Q2 | $374K | Buy |
+45,000
| New | +$374K | 0.01% | 425 |
|
|
2016
Q1 | – | Sell |
-171,000
| Closed | -$1.79M | – | 568 |
|
|
2015
Q4 | $1.79M | Sell |
171,000
-24,800
| -13% | -$259K | 0.25% | 156 |
|
|
2015
Q3 | $1.31M | Buy |
195,800
+36,300
| +23% | +$243K | 0.03% | 629 |
|
|
2015
Q2 | $1.07M | Buy |
159,500
+85,900
| +117% | +$577K | 0.03% | 723 |
|
|
2015
Q1 | $499K | Buy |
+73,600
| New | +$499K | 0.01% | 1013 |
|
|
2013
Q4 | – | Sell |
-36,083
| Closed | -$274K | – | 741 |
|
|
2013
Q3 | $274K | Buy |
+36,083
| New | +$274K | 0.01% | 1282 |
|